Gene list
Applied filters:
COG category: Defense mechanisms
Gene type: CDS
Genomic element: chromosome II
Number of genes found: 32
Show UniProt / TrEMBL protein name | View in Fasta format (DNA) | View as list | ||||
# Vibrio fischeri ES114, ES114 >VFA0537 type I restriction-modification system methylation subunit MMTQQELEKYLWGAATTLRGTIDAGDYKQYIFPLMFFKRICDVYDEEFEN ALAESDGDLEYAAFAENHHFQVPKGAHWNDVRETTTNIGLALQNAMRAIE KANPDTLEGIFGDASWTNKERLSDAMLTNLIEHYSEQTLNLKNVPDDKLG NAYEYLIKEFADDSGHTAAEFYTNRTVVKLMTMIMAPQPGESVYDPTCGS GGLLLNCALHLKDEGKEYRTLKLYGQEINLLTSAIARMNMFMHGIEEFDI VRGNTLSNPGLLENDELKKFNVILANPPYSIKSWDRKAFESDPYGRNVWG TPPQGCADYAFQQHIQKSLDLGNGRSISLWPHGILFRDAETAMRRKMIEQ DQVECVIGLGPNLFYNSPMEACLLITKTNKIESKKDKILFINAVKEVRQD KNIGYLDQVHIDKIFNAYNKFENEDSFAVLVDKQEVLDKKANMAINLYIR PDSLVSSEEACFATAYQEWQQSSGDLKQSMEKLFKELV >VFA0535 type I restriction-modification system methylation subunit MIEKLTLSQLEQYLSKAAWILKGPVDASDFKVYIFPLLFFKRISDVYDEE YRVALEESDGDEEYASMPEMHRFEIPTGCHWRDVRETTTSVGITIEDALR GIEQANQEYLYGIFGDAQWSNKNKLSDELLINLVEHFSQYTLGNQNVEPD MLGNAYEYLIKHFADLTNKKAGEFYTPRSVVHLLGMILDPHEGETIYDPA CGTGGMLLECVDHLKDNKEDYRTLKLFGQEKNLTSSSIARMNMFLHGIED FEILRGDTLRHPAFFEADGLKTFDCVIANPPFSLKDWGSENWANDPYGRN IAGVPPKGNGDMAWVQHMVKSLNSTGRMTVVLPHGALFRKAAEGKIRKQL LDQDMLEAVIGLGPNVFYGTQLAACVMVFKQNKPADKKGKVMFIDASDQI RVGRAQNFLEPNHVQQIYDWYHNYQDVENYVKVASMDELAENDYNLNIPL YVEKIIEDNLPSVEEAMADLKQAWQASLEAEEKFKSVLKGFLK >VFA0509 multidrug resistance ABC transporter ATP-binding and permease protein MFKFFERLTTAFPEQEPNQPPKGLYAFCRHYTKGFEVPLIGMSLLSAVIA MIEVSLFGFMGQLVDWLSTHDRETFLAQEGQTLLLLGFLIVVIVPILLFI HSLLTHQTLLGNYPMAIRWQAHRYLLKQSVSFYSDDFAGRIATKVMQTAL AVRETVMKLLDVLVYVSVYFTSMVVMVGQADWRLMLPMLVWFAAYVAIQF HFVPKLKAISEQQADARSTMTGRVVDSYTNINTVKLFSHSKRETQYAEEG MEEFLGTVHKQMRLATGINISVEIINYLLVFSIAAVSITLWLDNVLSVGA IAIAISLALRVNGMSHWIMWEISSLFENLGTVTDGINTLSKPIEITDKEN ASELNVSKGTIKFDSVNFNYGENKSVINDLNLEIKPGEKIGLVGRSGAGK STLVNLLLRFHDVESGSISIDGQDIRDVTQDSLRSQIGMVSQDTSLLHRS IRDNIKYGRPDATDEDLFAATKQAQAHEFIETLTDSFGSKGYDAQVGERG VKLSGGQRQRIAISRVLLKDAPLLILDEATSALDSEVEAAIQDSLDELME GKTVIAIAHRLSTIAAMDRLLVMDKGQVVEQGTHKELVALGGIYAQLWNH QTGGFISE >VFA0306 peptide transport system ATP-binding protein SapD MPLLDIRHLTIELETPQGMVKAVDRMSLTLNEGEIRGLVGESGSGKSLVA KAILGITKDNWKISADRMRLGNIDLLALSPKERRRVIGREMAMIFQEPST CLDPSEQVGNQLKEAIPSKYFTGSWWQRWNWRTKGAIALLHKVGIKDHKH IMKCYPYELTDGECQKVMIAMAIANKPRILIADEPTDELDAVTQSQIFRL LSRMNQVNNTTILLISHDLITLTQWVDRITVMYCGQSVESACRKDILEAP KHPYTNALLRAMPDFSKDGIPHKAKLESLPGTIPPLQHLPIGCRLGPRCP YAQRKCVQVPERQKVKDHKFSCHFPLNFEEKKNDCAS >VFA0656 hypothetical protein MYPDIILLNGTGSSGKTSLAKELQELLSIQYLNFSIDSVLYALPPTDLRR MIAGDPISRSGYDYGQLTEGYHNCVKGLLEAGCRLIIDNAWINEDEINAL EKSLSGFNVVRVKVMCRLDVCIARELARGDRAIGLAESEYPLVHNFIKYD ASVDTSDIQPKDAAVKLLRELKLY >VFA0589 integral membrane protein MSLFLLIQKEAKAIFSNTTIVLAMIGGVLFYAFLYPLPYQHQSPEEQKIS VVDLDKSELSRKFARMVNTSQQVNVVEQANSIEQAKSQFLNNEITGFLVI PSEFSKKLQLGEAPTVGYAGDASYFLIYGTIVEGLMTAGGTISAEYRIAH LAIDGTPMNAAIHSFRPFQSNYIPVFNHYMGYVQYVVPAVFVLILQQTLL MAVGVRQKQSSANENTVTHLIVRFGIFLFTELLLACLYFGYFFDFYSISR FGTPLEILVLLVPFISSVILLGLFLGKVLPTSESILLLVLFSSMPIVFSA GFIWPAEMVPSIITDIMHLLPSGFAINGFLKLNQQGAGLGGVLTNLSGLY ARCILYAFLFFITRNKNNLKGDTE >VFA0539 type I restriction-modification system restriction subunit MGFTELNSVEHYIIHQISGVNLNDAQCKNQVSEPQATYALQWQFKSSEQL GRDVNEVLVESELVKALIRLNPEIEANPHLADEVIHKLRAILISVNQVGL VKANEEFFAWMTGEKTMPFGENNRHVPVKLIDLEDLTRNGYVVTNQFRIH HRETKIPDVVLMINGIPVVVGEAKTPIRPSVSWLDGAHEVHNIYENAVPQ LFVPNILSFATEGKELFYGAIRCPLEFWAPWRTEEDDNSKGIGQVSKALG LTEIGKELIDLLSPVRLLDIMRNFSLFTTNKKKQRIKVIPRFQQYEGANK IVERVIEGKIKKGLIWHFQGSGKSLLMVFAAQKLRRTAQLKSPTVIVLVD RTDLDTQISGTFNAADVANVESTDSIKELQRMLERDTRKIIISMIHKFRD AKPNMNTRENIIVLVDEAHRTQEGDLGRQMRAALPNAFLFGLTGTPVNKA DKNTFWAFGAEEDKGGYMSRYTFHDSIRDEATLPLHFEPRLVDVHVDKEA LDKAFKDFKESAALSDEEADALNQKSAKMSAFLKSPERVEKIVEDIAIHF MDKVEPHGFKAMVVTPDREACVQYKEELDKHFPESASKVVISTSANDDFE FKQKWGVDKSQQEKLVDEFNDEKSDLKFLVVTAKLLTGFDAPICQTMYLD KSIKDHTLLQAICRTNRLYPNKTFGCIVDYFGVFDDAAKALEFDEESVQQ VISNLSELRSKLPQAMQDTLAHFIGVDRSLEGFEGLEAAQNAIGDNDKKD AFALDFKYLAKLWESLSPDSVLDEYNEDYKWLAQVYESVKPASDNIGKLL WLALGAQTTQLIHDNVHVGDVHNLEEFVLDADVIENIFNNPDPRKIKQLE KELAKRFKDRGDLPVFKSLSERLEELRDKAEKGLIASIDFVKELCKIAKE TVQAEKDLDDELQEKTPQAALTDLFLELKDDQTPAVVERIVTDIDAIVRI VRFPGWQTTTGGEREVQKSLRKALLKYKLHTDQTLFDRAYGYIKEYY >VFA0307 peptide transport system permease protein SapC MLSNNVYQEEHIPTQMERFWLSYRANSLAMFGFWCLLLIVIITVTSPWLS PYDPQWQSDYLLMPPSWSSEGEVIFFLGTDDLGRDILSRLLMGSQLTFGY AVIVALLSGFVGCVIGIFAGMTKGLLSSTLNHLLDTILSIPSLLLAIIFV AFLGFGEFNILLAIWLALIPRFVRAVYTAVHNEVEKDYILAARLDGANNF YLLWNSILPNILVVMVAEMTLAISIAILDITALGFLGLGAQAPSPEWGAM LGDSVELIYTAPWTVTLPGIVITFTVIIINLVGDGIQRALNAGTE >VFA0912 ABC transporter ATP-binding protein MELIMVLLLNNHNQFNQLRHRMNPIITVSSVSKHYPDSNQAQQALDNISF TLSSGQVLGLLGHNGAGKSTLINALLGAHRFSGNITINGLEPIENHAELM KHLAYISDVNVLPEWMTIKQILKYTSGVHPYFDINKALSLITKTNIKLGS KIGSLSKGMKVQIHLALVIATNVKVLILDEPTLGLDLLYRDNFYNDLMAW FNQGERCLIIASHEVNEIEKLLTDVLILKQGKCVKLDNMNNIPKGTLADL FITLQKEVI >VFA0111 daunorubicin resistance ATP-binding protein DrrA MTELAIQAKEVVKKFGDFTAIDGINLSVPKGSIYGFLGPNGCGKSTTIRT LTGLLSPTSGTVDVLGLCIPKESEALRLKIGYMTQKFSLYDDLSVEENLE FIGQIFGMEKQLLNARVSEQLATYGLDQLRKQRVSGMSGGQKQRLSLAAA TMHNPELLFLDEPTSAVDPENRREFWEQLFDLSDKGTTILVTTHYMDEAE RCHRLAIMESGIIRADGEPEELMANMGVNIVEVKANNLRALKAKLIACDE VRSAAQLGIRLRVLIHQHIDDPILWLRTNFSELKDAEMNIARPSLEDVFV TVTGKGRQ >VFA0046 transporter MNIAEYSIKNKVISWLFITILTIGGITSFLDLGRLEDPAFTIKDAMVVAT YPGATSKEVEEELTYPLEKAIRKLPYIDKITSTSSNGMSQIMVSMKMDYG PDELPQIWDEMRRKINDLKPTLPQGIQSLQIIDDFGDVFGVMMMLTGDDY NYVELKRYADTLTRELELIDGVGKISIAGDQQEMLFVEISLDRLAALNLD MNTVAGLLNQQNNVVQAGEVLVTWQQQLQRIRTKWQHYTTVESLGALDHP WP >VFA0047 acriflavin resistance plasma membrane protein MIIHGRDTGNLIRLKDVATITRGLQEKPGNIIRFNGKNALNIGLSFASGV NVVEVGQRVQEELTYLESIKPAGLELSYFYNQAQEVDTSVRDFIISLAEA VAIVIVVLLFAMGMRSGLIIGVVLLLTVFGTFILMSYNNIDLHRISLGAL IIALGMLVDNAIVVVEGILVGLKKGRTKVQAAADIVKQTQWPLLGATVIA IAAFAPIGLSEDATGEFMGDLYWVLCYSLFLSWVTAITITPFLADLLLKE EDKNTGVEEDAYKGFLFTAFGSSLKLALRFRWLTVASLVGLLVVAVMAFG NVKQQFFPASNTPMFYVDMWMPEGTDIRETIKQSEAVESYINKQDNIEFV SASIGQGMQRFALTYQPEKSYEAYAQFQIRTTDRESMFSLLENLTNSLDQ RFDKPTFQFKMMEFGPSPASKIEVRISGPDPQILRNLATNVEDIILTDPG SRNIRHDWRERTKELTPIFNESKARRLGISKEDLSNTLQMAFGGSTLGML RDGTHTLPIVTRLPESERVDFESLQNVKIWSPSLQTYIPVDQVIDGVNLD WSEPLIQRRDRKRTITVMADHDLLSDDTPASLLARIQPKVMELPLPEGYE ITWGGEYESSKDAQESLFGSLPMGYLFMFIITMLLFNSVKKPLKVIWFTV PLSIIGVAFGLLGTNMPFSFTAFLGLLSLSGMILKNGIVLLDQINLELAS GKDPYLAIVDSAISRVRPVSMAALTTILGLIPLLFDAFFSSMAITIMAGL GFATVLTLIVVPVMFAILFKIKPAAQTI >VFA0907 acriflavin resistance plasma membrane protein MLSKFFIHRPKFALVISLVMTLMGLIALKVLPIAEYPAISPTVIIVNTVY PGANADVVKKTVAQPLESKINGVEDMIYMSSNIGNDGSYSLRVYFRIGAD GDMAQVRVNNLVSQATSTLPPEVKQIGVTVRKKSSDILGVVTLSSPNKTY DSIYLSNYADLNLVERLKRLEGMSDITLLGKKSYSMRIWLNPNKMSTLNL TAKDVISAVKSQNIQVAAGKIGGMPAPDQQQNQYVLQTKGRLTSTDEFAN IVIRANKDGSIIRLSDVARLELGAQGYEADGQLNNQPAAVMALYQLPTAN ALDAMSKVKAAMKEYSKTFPDDLEYNIAYDSTEYVEASIDEVYETLIIAA LLVAIVVYVFLQNLRATAIPIIAIPVSIIATFAVMSLMGMTINTISLFGL ILAIGIVVDDAIIVVENVERIIHEKHMKPIPATIEAMKEVTGPVLATTLI LLAVFVPVALLPGISGKMFNQFAVTICVSVLISAINALTLSPALCGLILT DKHSEPIAPLRAFNRGFDAVTKKYQFLVGFMSQRLLVSSVIYIALIGVLG YTFMTIPTAFVPNEDKGAFMVEMRLPDSASLQRTIPILQDYTRDLLEMDG VEDVVSVSGFSLINMSAIPNAGMLIIKLNNWDDRKDPALHQKALMNKVRQ MLNTIPNANALVFATPAIRGMGSVDGFNFVLEDNLGRSPQELAQTTQNFV AKINQLPEVARAFSIFRANVPQRFIDVDRDKAISMGIPLNDIFQTLQSQL GGAYISDFNIYGRSFQVKVQAEQEYRDSTDDINNLYVRNNTGKMVSLGTL VKIKPIFGPDSLMNYNLFGSATINGVPASGYSSGDVVKAIEKLAENELPK GYSFEWSGMTYQELEAGNAAPVAFALSLLFTYLFLVAQYESWSIPTAVMM AVPIAILGAMATLFALGQPFDLYVQIGIVILIGMSAKVAILIVEFAKVLR EEKGYSIIEAAKEAARLRFRAVQMTAFAFIWGVFPLVIASGAGAESRHSL GFAVFGGMILSTLIGTIFTPVFFVTMQSLRERFNPKK >VFA0743 multidrug resistance protein A MQAAEQKFKQWMRILIVLFLIVTAYLVMADRLTPLTTQSKVQGFVVQISP EVSGRIVEVNHTNNQLVKKGELLFKIDDEKYLLAVQKAKIALAQAKEQEA SLVADIEAARSNVKTTQVTANNANREYHRIKRLANSGAVSASGLDSALTK RDQAAANLMAAKQKVHALEVKLGKGNGQSSAVLSAKNSLKQAELDLEHTQ VVAQNEGIITNMQLHVGVFANANQPLLTFIPTDSLWVSADYREKATSEMV KGMRAEVAYDAMPGEVFPLIVESRDYGVASAQQKANGQLSSVEVSNRWVR DAQRVRVNLTSDEPLSPRLFVGSRATVIIYTSGNSVIDYIGHSLITMISY LHYIY >VFA0112 export ABC transporter permease protein MKSMNRMKAIMMKEIRQLSRDKLTFGMVIMIPLIQLLLFGYAINTDIRDI PVAVVDQSESTLGRLITESVKVTQVVNIKQYYPTVEEAEKAIQQGVVRAA LVLPKDITQRVMQKRELGQWIVDGSDTMISAAILSLQTMPLADLDFDVRN TAKAKTFEVTLFYNPSRRSAVNIVPGLLGVILTMTMVLFTSSAIVRERER GNLELLITTPIRSFELMVAKIIPYIFVGLIQVLIILGLGYAIFDVPINGS LSQILFGTLLFISASLTLGLVISTIAKTQLQAMQMTIFILLPSILLSGFM FPYEGMPVIAQWIAEVLPATHFMRLIRGIVLRGADLMDLWRDTIWMIVFT LIGLFVASKRFKKSLD >VFA0896 multidrug resistance protein A MLEGLAVWALFIYLLRMVGMPWNKFTQAFAYIGGGSWLLFVWAGLLNYTP MDLSGGSVVQSPHIQLRPASTQIKGTVKAIHIEPNQEVKKGQLVYELDDE LYQIALNKAEVAFEASEVALAVAKQNVKLANQAIIASESDVVVSQKQIEA KSQDLKYKKLTLQRYVEQNRKVKNTITQSALDEQGTLVSIGEIEVASAIA QLDKAKLANEKAQLDFDNAKLGVKAKESELASAQESVTQAQWNLDNTKVY APADGYVTNFILREGQYVGTVPRMQMYTNEKYVLMRVNHQAIRNVKVGRP AEFSSAVYPGKIFVAEVEGIIEATGEAQANLLGRETNVRQTTGLNVNNKH HFVRLKLQEDQGYDIPVGSVGLAWVSGEKPIGFMAFLDVIRGIIIRMKSQ IYFFYSL >VFA0136 hypothetical protein MSVEYYVDKFRNLNMNSNKGRKSPHKVCMLLSVMDLIQAGYIYKNRFQLD ATLKERFTHFFNERRHEQDRDTPENPFFHLKSEGFWHLAYQDGIDASLVK GYSAKAINYAYLDDELFDYLKSIIVVNDLKDALVENLSDLTDLYTQWLID VGKSEKTAKNYSQAIRGSISNWMIQENILEEPLTKVKSFREFCRLSETAR SLEKFKKFNANGNHMYSAALNSYQRFLADLSQVDVKADIQEIFEDNKLTQ TEKTIMVNTRMGQGTFRKQLIEMWKGCSVTGYKNTQMLVASHIKPWREAN NTERLDKYNGLLLLANLDKAFDLGFISFQNSGKLMISSQLEAPEVLGLRD DMIFNVHREHKKYLDHHRKILFKGF >VFA0538 type I restriction-modification system specificity subunit MLDMEAVKNFSIDKSDWKKVKFGDVVFEPKESVKDPVSEGIEHVVGLEHI ESGDMYLRRSASIEGSTTFTKKFVKGDVLFGRRRAYLKKAAKAKFSGICS GDITVMRARDELLLPDLVPFIVNNEKFFDYAITHSAGGLSPRVKFKDLAN FEFFIPSKTDQKKLLSLLEGLDESLQNELILKQKLVSNLEAQIEHQIHGE HLDGKTINQVIKSLSSKKKIIKLKGLGEIIKGKGIAKSEVVESGIPCVRY GELYTKHHRMIRKFHSYISLKSSEKSVKLRVNDVLFAGSGETISEIGKSA AFTESVDAYAGSDILIFRPKDMDGSYLGYLMNSLLVRHQLNKLGTGATVM HVYGSDIQKIVVPYRDKDEQVQIANCLEEIASNIRLLDRKIHKTKELLAV LLSKVF >VFA0463 Lipoprotein releasing system ATP-binding protein LolD MSNPLLVCQGIRKVYQEGAMETEVLKGVDFQINGSELVAIVGSSGSGKST LLHILGALDEPTAGTVHFQENELTKLSANKQAKIRNQHIGFVYQFHHLLA DFSALENVAMPLLIGGVNKKEAAKRATELLEKVGLAHRIEHRPSELSGGE RQRVAIARALVNKPALVLADEPTGNLDHKTALDIYNLMRELNQESGTAFL VVTHDNELAAKLDKQLSMQDGRFITETVRSSLAQEMEA >VFA1165 type I protein secretion ATP-binding protein MKKWKAFNMKDSLLHSLCYVSRYYGQINSPEALINGLPLQDGKLTPFLFS RAAERAGLVAKENQGELLSIPQLILPVVLLLKGGESCVLIGFDAERKEAE IITLSSDMLPISISVEDLEAQYIGRYILLKKQFRYDDRSPEILKKREGHW FWSTLFESKHIYRDVFIASILINIFAIATPMFTRLVYDKVVPNLAFESLW VLASGIFVVFVFDFILKYLRGYFIDVAGKKSDVLISSKLFQKVLGIRMEA KPASVGAFARHLQEFESIRDFFTSATIASLIDLPFALLFLFIIYLIAGPI VLVPVVGITLLLIHAAIIQGPLKKTIEEGSRLSSQKYANLIESLVGLETL KIFNAQSQYQYRWEEAVTHISNWSIKSRRITDSIQNMAGFVQQAVNIGMI IVGVYLISNGDLTMGGLIASTMLSGKAIGPLVQISLLSSRYNQAKSSMTI IEELMAMPDEQEEEKRYIHRPILQGKIELDKVSFNYPEAEVAAVRDISLT INPGEKVAIIGRIGSGKTTLERLIMGLYKPTAGSVRIDDTDISQLHHVDV RRNIGCVPQDITLFYGSIRENIVLGRELSDDAEVMDAANRAGVTAFTQQD PAGLERQVGEGGLLLSGGQRQSVAIARALIGRPPVLLLDEPTSCMDNRTE MLFKNQLSHLKPAETLVLITHKTSMLDVVDRLIVMEKGHIITDGPKEQVL NELKTGKVRAVS >VFA0305 peptide transport system ATP-binding protein SapF MTALLEVTDLKKDYVFRTGLFRKQVREAVKPVSFSLEAGQTLGFIGANGS GKSTLARMLAGVVEPTSGIIKVNGEVLDYKDFQTRCKLIRMIFQDPNSSL NPRIQIGRILEGPLKRNTSMPPEARQQRVKDTLLRVGLLPEHAYFYPQML ATGQKQRVCLARALILQPSIIVADEALNGLDMAMRSQIINLFLELQQEMA ISFIYVSQHIGVVKHITDKVMVMHEGEVVEKGPTEEIFSNPQHSITQRLL ESHFDAPTHDRKQRISAATPKIEC >VFA0357 acriflavin resistance plasma membrane protein MDIARYTIAKRTSVWVLIALILFGGYLSYLKLGRFEDPEFVIRQAVINTP YSGATAQEVSDEVTDIIEGAVQSLQEVKEIKSVSKQGMSEVTVEIKLEFA GSQAELQQVWDKLRRKVGDAQRMLPPGAGASIVNDDFSDVYALFFAVTGD GFSDKQLQDYVDDLRRELVLVPGVAKTATLGERQETIFIEMSGERMAKFG VSAEKVYQVLQKQNMVTIAGSIETDSMRIPVIPSSNVNSFNDLINLQINL GDNNAVLRLGDIATVTRGYQEPQSMMVRYNGQRAVGFGISNVAGGNVVDM GDAVKARIAELENQRPLGIELNVISMQSDSVRASVTNFIDNLIAAVVIVF IVLLLFMGVRSGIIIGFVLLLTVAGTLCIMLIEDIAMQRISLGALIIALG MLVDNAIVVTDGILVRLQTTPNDSRDDIVSDVVNTTKWPLLGGTVVGICA FSAIGLSPSDMGEYAGSLFWVILYSMLLSWVFAVTITPMLCYDFLKVKPV DTQAPVGRVSRWYRQLLTWVIKHRVISLSLLLMVLFTSIYGAKYIPPGFM PESQRAQFVVDVYLPQGSDIKRTEQTIASIEQDIKQKAGITNITSFVGGG GLRFMLTYSPEARNPSYGQLLIDIDDYQNIAPLLGELQSELDEKYTDASI KVWKFMLGRGGGKKIEAGFKGPDSAVLRQLAEQAKTIMLNDPQLIAVQDD WRQQVPVLRPRYSEEKAQQFGLTTQEINQAIAQTLSGRNVGVYREGNDLI PIVARSPETERSHQRAIENTEVYSHAVGGFISVSQLVESTDVVWEDAILR RIDRMPTILVQADPAPGVLTADAFNQVRQKIEAIELPSGYELIWYGEYKA SKDANEGLVISAPYGFAAMILSVIFMFNALRQPLVIWLTAPLAIIGVTVG LIIFQTPFEFMAILGFLSLIGMMVKNAIVLVDQADAEIREGKLPYNAIID ASLSRARPVLLGALTTILGVAPLLIDPFFKSMAVTIMFGLLFATILTLIV IPLFYAMFFRIKAIEE >VFA0424 phospholipid-lipopolysaccharide ABC transporter MTIEKDESTWATFKRLWPHISLYKAGLGVAVVALVINALSDTYMISLLKP LLDEGFGSADSDFLKKMPFIILAMMFIRGLSGFVSGYCMSWVASNVVMRI RRQIFNHFMHMPVSYFDQESTGRLLSRITYDSEQVAAATSKALVNIVRES ASIIGLLGLMFWNSWQLSLVLVVIAPVVAFAISNVSKRFRKISKNMQTAM GSLTATSEQMLKGHKVVLSYGGQKVESERFDNISNHMRQQNMKMVVAQGL ANPIIQMIASFALVTVLYLASVDSIKETLTPGTFTVVFSAMFGLLRPLKG LTSVTSDFQRGMAACQTLFELMDMDKEKDDGTIEKDTVKGDIKVDNVTFT YPTADGPALRNVSFDLPAGKTIALVGRSGSGKSTIANLFTRFYDVDSGEI SLDGDKIEDYRLPNLRKHFALVSQNVHLFNDTVANNIAYASEGKFTRLEI EKAAELAYASDFINKMDDGFDTMIGENGASLSGGQRQRIAIARALLQNAP VLILDEATSALDTESEKAIQSALDELQKDKTVLVIAHRLSTIEDADQILV VDEGEVVERGNHAELIAHDGAYAQLHRIQFGD >VFA1149 acriflavin resistance plasma membrane protein MLSRFFIQRPKFALVISIILTLAGAIALAVLPVAEYPKISPPSVSVSAYY TGASAEVVEQAIADPIETSVNGVENMIYMSSKSANDGSYSLNVTFDVGTD PDMAQVNVQNRVAQIESKLPQEVRMVGVTVKKRSPDLLMVLNFYSPDGKY DDQFLINYVNLNIKDQLARVTGISEVGVLGGGEYAMRVWLDPDKMTNLGL TTSDVHAALAEQNVQVAAGKIGAAPYASAQDVQFNLVTKGRLESVEEFEN VVLRANNDGSSVYLKDIARVELGKKFYDGNGQFRGKDASIVTLSLQSDAN ALESGKAVMEMLEKLSATFPEGLAYETSYDTTLFVSESIKGVVKTLIEAI LLVIAVTYLFLGSARATLIPVVAIPVSLIGTFAVMLMTGFTINTVTLFGL ILAIGIVVDDAILVIENVDTIMKRDPSLSPRKATLIAMKEVTGPIITSTL VLLAVFIPVAMLPGITGIMYRQFALTICIAVIISSINALTLSPALCSLVL KRGGDNTARWFKAFNRGLDKVTDKYGEIAGFFVRKTMILMTFFVIALGAV TFFAKTTSTAFVPQEDKGILLVNVQLPDSASLSRTEEVSAKVLEIIEQEQ GVDGVTVANGYAFLTGAAASNGASLFVKLKPWGERNDMDGDNSSFAITNR INGRAAMELPEAVIFAMGAPAVPGMGAASGFEFVLEDTLGRSRTDLANVM NQVIQTANQQPEIQYTFSTFRANVPHYYVDIDREKAKQLGVSLGSIFQTL QGNLGSMYVNDFTMFGKNFRVTMQADGQYRSSMDDLDKFHVRASSGQMVP LSTLVTYDTVFEPDVAWRYNMYRSAVIQGQPAAGYSSGDAIAAMERVAAE VLPHGYQYEWTGMAYQEVKAGNQAIYAFALALIFIYLFMVAQYESWSIPL AIILVVPVATFGSFLALNLTGMPLNLYAQIGLVLLIALAAKNAILIVEFA KNEREEKEVGLDDASVNGGRLRFRAVNMTSWSFILGILPLVFASGAGYIS QNSLGVSLIGGLLCVLLVGTLLIPGFYAMVQRRREKLHGGSTKLIPLDDE >VFA0737 ABC transporter ATP-binding protein MISFKGIEKTYQLGLQRVEALKQVDGFIIKGSMVALCGPSGSGKSTLLNI LGLLDMDYQGEIKMDGEFYPKDPIEAAKLRRHQLGFVFQRFNLVPVMTAL ENVAYPLVLNGYSSKEQRILATEMLEKVGLGDVIHHRPDNLSGGQQQRVA IARALVHKPSLVIADEPTASLDSQTAETVIDIMKALGKEIGTTFIVATHD YRMAQHCDTCINLLDGTISKEAVSCAS >VFA0479 hypothetical protein MKVKFHLEKDKQPTSDNGMKIIYGSAKRGGYRFRWYCILALVLSPILIMA YVFFQQYILTLAPGIITTSPVVITAPQDSMVTAINVKEGNQITYGRNVLE LNDPVLDSDIQFIKTELTNLNKRKSKVQHDLKSYLLAIRNAKDNLESIKK IKLNYDKFIKEGKVSQVDYANIIGMYNSAQNTLTSADIGYQKALLDSVQV ELAGGIAQVVRSLNQELVTKLSQKKLLSIHSPYDGNIIEINTVVGQRIKK GDVLATIASKADPFVIAYLEPKFIEKAKEGSVVTVILPNRERLKGNVSLA IETTTKLPAQLAKPFEGPKSLLKVKVTLKKKITKEQWVEGMPVQVSF >VFA0916 Na(+) driven multidrug efflux pump MTTFHADSSITRTFWRYAIPSIAAMVVSGLYQIIDGIFVGHYIGFEGLAG INMAWPAICILGAIGVMVGMGTGSVMSIYRGENKLEKTKVALTTGFWLLA ILSIIAISCIVLLAKDILLAQGAEGQNFAYAMDYINVLMFGGFFTACATA LPMLVRNDESPNVATFLLVIGALINIVLDYVFIGVMGLGLSGAALATLMA QACVTVLGIGYFFTQRSSIQITLQEVLFSWNKAKQSLSLGASALVMYLYG SFVVAMHNALMMYYGSATTVGAYAIVGYLFMLYYLLAQGIAEGAQPPISY YFGARENKKVYQIFKIALKWVIITGIGWVTILNISPELTTALFTNGDKAL IAETIVGIRYHLFAMFLDGMIVLITIYFLSVNEGKKAMVISISNIVIQLP FLLILPKWFGIDGVWLAMPVSNIALIICIAPMVWNHLKTQKIIKPLPLTS TSVMSH >VFA0379 fusaric acid resistance protein fusE MDLLLILTYTALCIAVFKIFNIPLNKWTVPTAGLGGVVLVGTLVLLMNYN HPFTQFGGQFYVTTPIVPSVRGKVIEVNVTPNQPVAAGDVLFKIDPIPFQ AEVIRKQAALSEAEQAALQLESVYKSAQSNTIKATADKDKAYREFKRYEK GYKKGAFTAQQLDTRKQTYKASEATLESVQAQEQQAKLALESEINGENTT VARMRAELEQAQFNLDETIVKAPTDGYVTQMALRPGMMAVPIPLRPVMTF VHTEDQYFVGAFRQNSLQRLRAGFEAEFLFRAIPGRVFKGEVVEVIPAIG EGQIQASGALLGTNAIRTNGRALVKLKLTDDVSEFHLPAGSNAEISVYSD SFEHVSIMRKVLIRMKSWQNYLYLDH >VFA1103 multidrug resistance protein A MKKSRHFSITFTLFFISSLIGYLIYFAWQYSNNHPSTENAYVRAKIVSIA PQIKGRIISVEVNDYQKVNKGDLLLKIDPQPYLLAVKRAESAYQLAVQQH QVADSKVTQAIANLNGVTSNLKETQIEFKRTQALVSRKLSSQQELDIIKN KLAIAQAKLEEARANVEAAIANRGDDNGVDAAIVQQASAELAQAELDLSY TDITAPTDGLLGEINVFVGSVVKNSQMLFPLVVKNTYWVRANFKETSLTN IRMGQTAEVVIDMYPDITWQAKVSELSPASGTSFSLMPPENATGNWVKIK QRYPVKLILDIPKDSPQLRIGASAEVTINLSDDSRT >VFA0590 daunorubicin resistance transmembrane protein MISMKTYWRSYFTSPWVMAVTFVLPLLTSLVIWWIFSSNVVRELPIDVVD LDQSHLSRMMIRDYDATPTLSVKSIQPNKEKANLALTKGDNYGYIIIPHD FEKNVMLGKSPKITGFYNGQFILIAKQINSALMQTDMTAQAKLSVIKQLS IKETTWTQAINSAVPIKVQVTPLFNLGSNYNQFLVSAILPAIWQMAVIVG MLWAMQNESVRTGCNSLREWFDKQDRLSIFNFTLVYFCIAMMLGAVLFYF LYGVIGFPFNGSITAFILNMSLMSFACISLGIAIGYGTNDIVKAMSISGA YTAPSFAFLGVTFPVTDMNSLATFWHSILPASHFVRAQNELSNYGDSLVS AFPNIGVLTLFTLPLLLLSLKLKK >VFA0467 hypothetical permease MDVKFHLEKKNKPTSDNGMKVLYGMEKRGAYRFRWYLILAIILSPIFFMI YTFAKQHLFTVAPGIITTGPVIITASQNGTVKLIDVKDSEFVLEDQLLME LDAPILEQEIEFIENELEQLYQEQTQKITEDFGPYISAIGAAKLNLKKIT KIKVNYDQYAKEGKVSQVDYAAIVGIYNTAQNNLTNAYIALNQAEIAQKQ RLLAGGVAQVTRELNQALTTKKNQLDALSIRAPYMGLVIDINALKGQQIS IGDPLVTVSPDVAPYVISYLDPKHIEKAKLGALVTVKLPNGKKVEARVSS AIGLTSKLPIQLAKPFEGAKALLKVKITFLGGVLEKEWVEGMPVEVYF >VFA0308 peptide transport system permease protein SapB MWIYTIRRFNLFVITLLILTLIGFNILRLDDTSAWAQTPFLSGWLTYLGQ LLNGNLGVNQYGVKMLNEILRVFPATIELCFFAFFIALIIGTPIGTIAGM RRGKPLDTLISSIALVGYSMPLFWIALLGLQLGVTPVSGRYSLLYEFDAK TGFAFIDVLASKSPYRAEMLENIIQHLILPTLVLSIAPMTEVVRLMRSSV ATVITQNYIKVAHTKGLSKFEIMVKHIIRNALPPIIPKLGVQLSGLFTAA ILTESIFNWPGIGHWLLDAIINQDFVAIQAGVITVASFILLANILSDLLG AAVNPLVRKEFYALK